摘要
2018年,美国糖尿病学会(ADA)、欧洲糖尿病研究协会(EASD)、中华医学会糖尿病学分会(CDS)、中国老年医学学会(CGS)及中国微循环学会(CSM)等组织就糖尿病及其并发症发布一系列指南和共识,关于糖尿病分级预防、糖尿病诊断标准、糖尿病患者血压血脂要求、糖尿病患者综合管理、降糖药物的疗效和不良反应等有新的建议和推荐。上述内容对糖尿病的预防、诊断、治疗及糖尿病后续研究都具有重要和深远的意义,对此进行综述。
In 2018,American Diabetes Association(ADA),European Association for the Study of Diabetes(EASD),Chinese Diabetes Society(CDS),Chinese Geriatrics Society(CGS)and Chinese Society of Microcirculation(CSM),etc.published several guidelines and statements on diabetes and its complications.The prevention of diabetes,diagnostic criteria of diabetes,the characteristics of blood pressure and blood lipid,integrated management of diabetes,the efficacy and adverse reaction of hypoglycemic drugs were also suggested and recommended.These guidelines and statements play key roles in the prevention,diagnosis,treatment and future research of diabetes mellitus,which is reviewed in this article.
作者
李春雨
易祖木
赵呈智
张雨薇
LI Chun-yu;YI Zu-mu;ZHAO Cheng-zhi;ZHANG Yu-wei(West China School of Medicine,Sichuan University,Chengdu 610041,China)
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2019年第6期533-536,共4页
Chinese Journal of Practical Internal Medicine
关键词
糖尿病
指南
共识
药物安全
diabetes mellitus
guideline
consensus
drug safety